Integra Resources Corp. Sees Significant Growth in Short Interest
| IART Stock | USD 18.88 0.23 1.20% |
Slightly above 61% of Integra LifeSciences' investor base is looking to short. The analysis of overall sentiment of trading Integra LifeSciences Holdings stock suggests that many investors are alarmed at this time. Integra LifeSciences' investing sentiment can be driven by a variety of factors including economic data, Integra LifeSciences' earnings reports, geopolitical events, and overall market trends.
Integra |
Integra Resources Corp. saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 565,400 shares, a growth of 58.3 percent from the September 15th total of 357,200 shares. Based on an average daily volume of 141,700 shares, the days-to-cover ratio is currently 4.0
Read at thelincolnianonline.com
 |
Integra LifeSciences Fundamental Analysis
We analyze Integra LifeSciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integra LifeSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integra LifeSciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Integra LifeSciences is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Integra LifeSciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Integra LifeSciences stock to make a market-neutral strategy. Peer analysis of Integra LifeSciences could also be used in its relative valuation, which is a method of valuing Integra LifeSciences by comparing valuation metrics with similar companies.
Peers
Integra LifeSciences Related Equities
| HAE | Haemonetics | 3.44 | ||||
| MMSI | Merit Medical | 0.55 | ||||
| CNMD | CONMED | 0.02 | ||||
| ICUI | ICU Medical | 1.25 |
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.